Portfolio Update

RNS Number : 1339L

Intl. Biotechnology Trust PLC

23 April 2015

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC      

Portfolio Update as at 31 March 2015                                                                                    

Net Assets	£249m
Net Assets per share	600p
Share price	540p
Total value of unquoted investments	£18m
Total number of portfolio companies	86

Top Ten Holdings

Company Name	% NAV
Biogen	8.6
Celgene	7.9
Gilead	6.8
Amgen	6.2
Regeneron	5.7
Incyte	4.8
Vertex	4.6
Alexion	3.8
Mylan	3.5
Chimerix	2.9
	-----------
Total	54.8
Portfolio Profitability	% NAV
Profitable	58
Turning Profitable 2015	6
Unprofitable	36
	-----------
Total	100

Geographical Allocation	% NAV
US & Canada	90
Europe & UK	10
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	93
Unquoted	7
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

23 APRIL 2015

 

END

 

 

PFUBBGDSLDDBGUX